If you’ve struggled with depression and tried two or more antidepressants without relief, you may have treatment-resistant depression (TRD). You could benefit from a different kind of medication. Spravato is a FDA-approved nasal spray containing esketamine that when taken with your antidepressant can lead to wonderful benefits for your mental health.

Is Spravato right for you?

Spravato (esketamine) is typically prescribed for adults with treatment-resistant depression (TRD). A good candidate for Spravato has not responded adequately to at least two different antidepressants from two different classes during their current depressive episode. Spravato is approved for use in adults. It is not prescribed for children or adolescents.

Spravato can begin to alleviate symptoms of depression within hours to days, which is significantly faster than traditional antidepressants that often take weeks to show effects. Spravato has been shown to be effective in individuals who have not responded to other antidepressant treatments. This makes it a valuable option for those with TRD. Clinical studies have demonstrated that Spravato can significantly reduce depressive symptoms in many patients, leading to an overall improvement in mood and functioning. By reducing depressive symptoms, Spravato can enhance overall quality of life, including improvements in daily functioning, social interactions, and overall well-being.

Experience a new path to mental well-being with Spravato. If traditional antidepressants haven’t worked for you, this FDA-approved nasal spray could be the breakthrough you need, offering rapid relief and a brighter outlook on life. Don’t let treatment-resistant depression hold you back—discover the transformative potential of Spravato today!

Meet with one of our practitioners today to see if adding Spravato is right for you. Contact us today! 225.254.9589